- Home
- INBX vs BVS Comparison
INBX vs BVS Comparison
Compare INBX & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBX
- BVS
- Stock Information
- Founded
- INBX 2010
- BVS 2011
- Country
- INBX United States
- BVS United States
- Employees
- INBX N/A
- BVS N/A
- Industry
- INBX Biotechnology: Pharmaceutical Preparations
- BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- INBX Health Care
- BVS Health Care
- Exchange
- INBX Nasdaq
- BVS Nasdaq
- Market Cap
- INBX 430.2M
- BVS 448.8M
- IPO Year
- INBX 2020
- BVS 2021
- Fundamental
- Price
- INBX $33.88
- BVS $6.64
- Analyst Decision
- INBX Hold
- BVS Strong Buy
- Analyst Count
- INBX 2
- BVS 5
- Target Price
- INBX N/A
- BVS $14.40
- AVG Volume (30 Days)
- INBX 123.8K
- BVS 294.3K
- Earning Date
- INBX 11-13-2025
- BVS 11-04-2025
- Dividend Yield
- INBX N/A
- BVS N/A
- EPS Growth
- INBX N/A
- BVS N/A
- EPS
- INBX N/A
- BVS 0.03
- Revenue
- INBX $1,400,000.00
- BVS $564,142,000.00
- Revenue This Year
- INBX $563.00
- BVS N/A
- Revenue Next Year
- INBX $230.77
- BVS $6.88
- P/E Ratio
- INBX N/A
- BVS $240.50
- Revenue Growth
- INBX N/A
- BVS 5.08
- 52 Week Low
- INBX $10.81
- BVS $5.81
- 52 Week High
- INBX $37.53
- BVS $14.38
- Technical
- Relative Strength Index (RSI)
- INBX 70.20
- BVS 42.20
- Support Level
- INBX $31.75
- BVS $6.46
- Resistance Level
- INBX $37.53
- BVS $7.14
- Average True Range (ATR)
- INBX 1.99
- BVS 0.26
- MACD
- INBX 0.27
- BVS -0.02
- Stochastic Oscillator
- INBX 67.38
- BVS 34.67
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About BVS Bioventus Inc.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.